(Q46005588)

18 December 2017

title

Development and validation of a robust and versatile one-plasmid regulated gene expression system. (English)

1 reference

18 December 2017

author name string

Paul Szymanski

1

1 reference

18 December 2017

Peter J Kretschmer

2

1 reference

18 December 2017

Maxine Bauzon

3

1 reference

18 December 2017

Fang Jin

4

1 reference

18 December 2017

Hu Sheng Qian

5

1 reference

18 December 2017

Gabor M Rubanyi

6

1 reference

18 December 2017

Richard N Harkins

7

1 reference

18 December 2017

Terry W Hermiston

8

1 reference

18 December 2017

publication date

1 May 2007

1 reference

18 December 2017

published in

Molecular Therapy

1 reference

18 December 2017

volume

15

1 reference

18 December 2017

issue

7

1 reference

18 December 2017

page(s)

1340-1347

1 reference

18 December 2017

Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Dimerizer-regulated gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Adenovirus-mediated regulable target gene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Antiprogestin-controllable transgene regulation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

The antiprogestin-dependent GeneSwitch system for regulated gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Regulatable atrial natriuretic peptide gene therapy for hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

A gene regulation system with four distinct expression levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Quantitative analysis of the packaging capacity of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Plasmid-mediated muscle-targeted gene therapy for circulating therapeutic protein replacement: a tale of the tortoise and the hare?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300171

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300171

1 reference

18 December 2017

1 reference

18 December 2017